Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
Lang Rao(National Institutes of Health), Jing Mu(University of California San Diego), Liangcan He(National Institutes of Health), Fei Kang(Xijing Hospital), Shukun Zhao(Wuhan University), Churan Wen(Nanfang Hospital), Zhèn Yáng(National Institutes of Health), Guangyu Yao(Nanfang Hospital), Ni Xie(Shenzhen Second People's Hospital), Rui Tian(National Institutes of Health), Yue Sun(Wuhan University), Bo Cai(Union Hospital), Lisen Lin(National Institutes of Health), Qian‐Fang Meng(Shenzhen Bay Laboratory)
Cited by 278
Related Papers
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
|Nature Communications|2020|373
Multiplexed NIR‐II Probes for Lymph Node‐Invaded Cancer Detection and Imaging‐Guided Surgery
|Advanced Materials|2020|264
Supramolecular Polymerization‐Induced Nanoassemblies for Self‐Augmented Cascade Chemotherapy and Chemodynamic Therapy of Tumor
|Angewandte Chemie International Edition|2021|252
Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging
|ACS Applied Materials & Interfaces|2017|246
Platelet–Leukocyte Hybrid Membrane‐Coated Immunomagnetic Beads for Highly Efficient and Highly Specific Isolation of Circulating Tumor Cells
|Advanced Functional Materials|2018|225